Cargando…
Critical Implications of IVDR for Innovation in Diagnostics: Input From the BioMed Alliance Diagnostics Task Force
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126521/ https://www.ncbi.nlm.nih.gov/pubmed/35620593 http://dx.doi.org/10.1097/HS9.0000000000000724 |
| _version_ | 1784712148115521536 |
|---|---|
| author | Dombrink, Isabel Lubbers, Bart R. Simulescu, Loredana Doeswijk, Robin Tkachenko, Olga Dequeker, Elisabeth Fraser, Alan G. van Dongen, Jacques J. M. Cobbaert, Christa Brüggemann, Monika Macintyre, Elizabeth |
| author_facet | Dombrink, Isabel Lubbers, Bart R. Simulescu, Loredana Doeswijk, Robin Tkachenko, Olga Dequeker, Elisabeth Fraser, Alan G. van Dongen, Jacques J. M. Cobbaert, Christa Brüggemann, Monika Macintyre, Elizabeth |
| author_sort | Dombrink, Isabel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9126521 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91265212022-05-25 Critical Implications of IVDR for Innovation in Diagnostics: Input From the BioMed Alliance Diagnostics Task Force Dombrink, Isabel Lubbers, Bart R. Simulescu, Loredana Doeswijk, Robin Tkachenko, Olga Dequeker, Elisabeth Fraser, Alan G. van Dongen, Jacques J. M. Cobbaert, Christa Brüggemann, Monika Macintyre, Elizabeth Hemasphere HemaPolicy Lippincott Williams & Wilkins 2022-05-20 /pmc/articles/PMC9126521/ /pubmed/35620593 http://dx.doi.org/10.1097/HS9.0000000000000724 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | HemaPolicy Dombrink, Isabel Lubbers, Bart R. Simulescu, Loredana Doeswijk, Robin Tkachenko, Olga Dequeker, Elisabeth Fraser, Alan G. van Dongen, Jacques J. M. Cobbaert, Christa Brüggemann, Monika Macintyre, Elizabeth Critical Implications of IVDR for Innovation in Diagnostics: Input From the BioMed Alliance Diagnostics Task Force |
| title | Critical Implications of IVDR for Innovation in Diagnostics: Input From the BioMed Alliance Diagnostics Task Force |
| title_full | Critical Implications of IVDR for Innovation in Diagnostics: Input From the BioMed Alliance Diagnostics Task Force |
| title_fullStr | Critical Implications of IVDR for Innovation in Diagnostics: Input From the BioMed Alliance Diagnostics Task Force |
| title_full_unstemmed | Critical Implications of IVDR for Innovation in Diagnostics: Input From the BioMed Alliance Diagnostics Task Force |
| title_short | Critical Implications of IVDR for Innovation in Diagnostics: Input From the BioMed Alliance Diagnostics Task Force |
| title_sort | critical implications of ivdr for innovation in diagnostics: input from the biomed alliance diagnostics task force |
| topic | HemaPolicy |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126521/ https://www.ncbi.nlm.nih.gov/pubmed/35620593 http://dx.doi.org/10.1097/HS9.0000000000000724 |
| work_keys_str_mv | AT dombrinkisabel criticalimplicationsofivdrforinnovationindiagnosticsinputfromthebiomedalliancediagnosticstaskforce AT lubbersbartr criticalimplicationsofivdrforinnovationindiagnosticsinputfromthebiomedalliancediagnosticstaskforce AT simulesculoredana criticalimplicationsofivdrforinnovationindiagnosticsinputfromthebiomedalliancediagnosticstaskforce AT doeswijkrobin criticalimplicationsofivdrforinnovationindiagnosticsinputfromthebiomedalliancediagnosticstaskforce AT tkachenkoolga criticalimplicationsofivdrforinnovationindiagnosticsinputfromthebiomedalliancediagnosticstaskforce AT dequekerelisabeth criticalimplicationsofivdrforinnovationindiagnosticsinputfromthebiomedalliancediagnosticstaskforce AT fraseralang criticalimplicationsofivdrforinnovationindiagnosticsinputfromthebiomedalliancediagnosticstaskforce AT vandongenjacquesjm criticalimplicationsofivdrforinnovationindiagnosticsinputfromthebiomedalliancediagnosticstaskforce AT cobbaertchrista criticalimplicationsofivdrforinnovationindiagnosticsinputfromthebiomedalliancediagnosticstaskforce AT bruggemannmonika criticalimplicationsofivdrforinnovationindiagnosticsinputfromthebiomedalliancediagnosticstaskforce AT macintyreelizabeth criticalimplicationsofivdrforinnovationindiagnosticsinputfromthebiomedalliancediagnosticstaskforce |